Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
Dan Pan1, An Zeng2, Baoyao Yang2
1School of Electronics and Information, Guangdong Polytechnic Normal University, Guangzhou, 510665, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|December 27, 2022
Summary
This study introduces an interpretable deep learning model to track Alzheimer's disease (AD) progression using brain MRI scans. The model identifies specific brain regions showing early neurodegeneration, aiding in predicting AD advancement.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Neurology
Background:
- Deep learning (DL) excels at differentiating Alzheimer's disease (AD) using brain MRI.
- The utility of DL in detecting progressive structural MRI (sMRI) abnormalities in AD remains underexplored.
Purpose of the Study:
- To propose an interpretable DL algorithm, Ensemble 3DCNN, for investigating longitudinal sMRI changes in AD.
- To identify patterns of neurodegeneration indicative of AD onset and progression using whole-brain sMRI.
Main Methods:
- Utilized 2369 T1-weighted sMRI scans from ADNI and OASIS cohorts.
- Developed and validated an Ensemble of 3D convolutional neural network (Ensemble 3DCNN).
- Generated an Ensemble-3DCNN-based P-score for pattern analysis of neurodegeneration.
Main Results:
- Identified early and connected neurodegeneration in amygdala, insula, parahippocampus, and temporal gyrus.
- Observed complex individual variability in sMRI changes.
- Confirmed AD pathological progression through patterned sMRI changes detected by the DL model.
Conclusions:
- Interpretable DL combined with non-invasive sMRI can detect patterned brain changes associated with AD progression.
- This approach offers new insights into predicting AD progression using whole-brain sMRI data.
Related Concept Videos
Brain Imaging
278
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
278
Alzheimer's Disease: Overview
602
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
602


